Experiment 644616
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | ZHOU,DF: ZHANG,XY: SU,J: NAN,ZG: CUI,Y: LIU,J: GUAN ZQ: ZHANG,PY: SHEN,YC:. (1999). THE EFFECTS OF CLASSIC ANTIPSYCHOTIC HALOPERIDOL PLUS THE EXTRACT OF GINKGO BILOBA ON SUPEROXIDE DISMUTASE IN PATIENTS WITH CHRONIC REFRACTORY SCHIZOPHRENIA.. 112(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN 54 PATIENTS WITH CHRONIC REFRACTORY SCHIZOPHRENIA, 27 WERE TREATED WITH HALOPERIDOL PLUS EGB (GROUP 1), AND THE REST RECEIVED HALOPERIDOL PLUS PLACEBO (GROUP 2). SUPEROXIDE DISMUTASE (SOD) LEVELS OF THESE PATIENTS WERE MEASURED BEFORE AND AFTER TREATMENT AND COMPARED WITH THE LEVELS OF 25 HEALTH VOLUNTEERS. THERAPEUTIC EFFICACLY WAS EQUATED WITH A CHANGE IN CLINICAL RATING SCORES ASSESSED BY STANDARDIZED MEASUREMENT TOOLS INCLUDING THE SCALE FOR ASSESSMENT OF POSITIVE SYMPOTMS (SAPS) AND THE SCALE FOR ASSESSMENT OF NEGATIVE SYMPTOMS (SANS). EGB MAY ENHANCE THE EFFICACY OF CLASSIC ANTIPYCHOTIC HALOPERIDOL ON SCHIZOPHRENIA, ESPECIALLY ON POSITIVE SYMPTOMS. IT MAY WORK THROUGH AN ANTIOXIDANT EFFICACY THAT IS INVOLVED IN TTHE THERAPEUTIC MECHANISM. A COMMERCIAL PRODUCT, EGB-761, WAS USED. |
| Dose amount | 360.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETOH(100%)EXT |
| Gender | GIVEN TO BOTH SEXES |